Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 269Neoplasms 148Breast Neoplasms 146Colorectal Neoplasms 128Neoplasm Metastasis 96Prostatic Neoplasms 95Multiple Myeloma 94Ovarian Neoplasms 93Lung Neoplasms 88Squamous Cell Carcinoma of Head and Neck 64Pancreatic Neoplasms 64Recurrence 62Endometrial Neoplasms 58Small Cell Lung Carcinoma 52Melanoma 52Stomach Neoplasms 50Leukemia, Lymphocytic, Chronic, B-Cell 48Carcinoma, Renal Cell 47Leukemia, Myeloid, Acute 46Lymphoma, Non-Hodgkin 41Advanced Solid Tumors 40Urinary Bladder Neoplasms 38Triple Negative Breast Neoplasms 38Parkinson Disease 4, Autosomal Dominant Lewy Body 38Head and Neck Neoplasms 38Lymphoma, Large B-Cell, Diffuse 36Carcinoma, Hepatocellular 35Esophageal Neoplasms 32Lymphoma, Follicular 30Colonic Neoplasms 29

Interventions

tocilizumab 1obinutuzumab 1glofitamab 1Oxaliplatin 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Cytokine Release Syndrome × 30 days × Clear all
NCT07609940 2026-05-27

POPLIN

Regeneron Pharmaceuticals

Phase 4 Not yet recruiting
30 enrolled
Plasma cell

Cytokine Release Syndrome, Multiple Myeloma

NCT06806033 2026-05-26

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Hoffmann-La Roche

Phase 2 Recruiting
100 enrolled
Lymphoid

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡